GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Popular weight-loss drugs like Ozempic and Zepbound have revolutionized how we tackle obesity. But now, emerging reports ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...

A new class of medications — called glucagon-like peptide 1 receptor agonists, or GLP-1s — has taken the country by storm because these drugs seem to make weight loss more effortless.

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

Projections for the near future indicate that the glucagon-like peptide GLP-1 agonists weight loss drugs market size will continue to surge, reaching $28.91 billion in 2029 at a CAGR of 16.6%.

The history of weight-loss drugs is littered with failures. Some were outright dangerous: In the 1950s and ’60s, amphetamine-based diet pills were popular, but their prominence faded after being ...

Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to ...

Two major metabolic responses to glucagon have previously been demonstrated. 5 Normal subjects receiving 0.5 mg. intravenously show a ... and the departments of Preventive Medicine, Medicine and ...